Mirscience Therapeutics is a biotechnology startup that develops RNA molecules for the treatment of muscle and metabolic diseases. Through Mir-Plataform, the company prospects and develops microRNA/siRNA molecules for the treatment of diseases such as cachexia associated with cancer and sarcopenia in aging.